FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF’s New Video Offers Insights into Multinational Rare Disease Clinical Trials
We are proud to share with you the newly released informative video detailing the challenges and strategies involved in conducting the DEEP- [...]
CVBF at the ERAMET Kick-Off Meeting
Namur, Belgium - CVBF participated in the kick-off meeting of the ERAMET project on March 4-5 in Namur that was organized by [...]
29 February 2024, Rare Disease Day
29 February is Rare Disease Day, falling on the rarest date of the calendar. This is an opportunity to raise awareness that [...]
CVBF’s CEO selected as Permanent Member of the Advisory Group of the ACT EU Multistakeholder Platform (MSP AG)
On 20 December 2023, Donato Bonifazi, our CEO, has been selected as a permanent member of the Advisory Group [...]
CVBF Wins ERAMET Project, Funded by Horizon Europe
CVBF has achieved a major milestone by securing a significant role in the Horizon Europe-funded ERAMET project. Guided by Prof [...]
New Clinical Trial Seeks to Slow Progression of Nearsightedness in Children
A new international clinical trial is underway across Europe to test whether low-dose atropine eye drops can effectively slow the [...]
13 Organizations Across Europe Join Forces for Novel ATMP on Faecal incontinence.
CVBF provides regulatory, site management, and monitoring support for the AMELIE (Anchored Muscle cELls for IncontinencE) project, Ana Dilo as [...]
The use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
According to the European Medicines Agency (EMA), from 31 January 2023, all initial clinical trial applications in the European Union (EU) must be submitted via [...]
Implementation in the Italian legal system of the European Regulation 536/2014 on clinical trials
The Italian Minister of Health has signed the four decrees on Ethics Committees, thus taking a decisive step towards the full implementation in the Italian [...]
CVBF is about to start a project to speed up and facilitate the diagnosis of celiac disease
The consortium consisting of IRCCS Materno Infantile “Burlo Garofolo” (Project Leader), Azienda Ospedaliera Universitaria Federico II, Azienda ULSS2 Marca Trevigiana and Consorzio per Valutazioni Biologiche [...]
Survey: International Clinical Trials Registry Platform (ICTRP) search portal user experience
In order to improve the user experience of the International Clinical Trials Registry Platform (ICTRP) search portal, the World Health Organization (WHO) is seeking input [...]
CVBF spotlight on scientific literature: “Why children have to wait years for new drugs”
This recent article is part of Nature Outlook: Children‘s health and focuses on the lack of medicines approved for paediatric use. According to the article, [...]
First gene therapy to treat haemophilia B
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Hemgenix (etranacogene dezaparvovec), the the first gene therapy for the treatment [...]